Avricore Health Inc - Asset Resilience Ratio

Latest as of September 2025: 0.75%

Avricore Health Inc (AVCR) has an Asset Resilience Ratio of 0.75% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Avricore Health Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CA$10.00K

≈ $7.23K USD Cash + Short-term Investments

Total Assets

CA$1.33 Million

≈ $961.59K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2008–2024)

This chart shows how Avricore Health Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see AVCR total asset value.

Liquid Assets Composition Over Time

This chart breaks down Avricore Health Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of Avricore Health Inc for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$10.00K	0.75%
Total Liquid Assets	CA$10.00K	0.75%

Asset Resilience Insights

Limited Liquidity: Avricore Health Inc maintains only 0.75% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Avricore Health Inc Industry Peers by Asset Resilience Ratio

Compare Avricore Health Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
GeneDx Holdings Corp. NASDAQ:WGS	Diagnostics & Research	15.00%
Shanghai Runda Med Tech Co SHG:603108	Diagnostics & Research	0.42%
Shanghai Rendu Biotechnology Co. Ltd. A SHG:688193	Diagnostics & Research	70.50%
DIVA Laboratories Ltd TWO:4153	Diagnostics & Research	0.01%
Genoray Co. Ltd KQ:122310	Diagnostics & Research	2.14%
RHYTHM Biosciences Ltd AU:RHY	Diagnostics & Research	2.74%
Check-Cap Ltd F:7CC	Diagnostics & Research	2.90%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%

Annual Asset Resilience Ratio for Avricore Health Inc (2008–2024)

The table below shows the annual Asset Resilience Ratio data for Avricore Health Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.44%	CA$10.00K ≈ $7.23K	CA$2.30 Million ≈ $1.66 Million	+0.04pp
2023-12-31	0.39%	CA$10.00K ≈ $7.23K	CA$2.54 Million ≈ $1.84 Million	+0.00pp
2022-12-31	0.39%	CA$10.00K ≈ $7.23K	CA$2.57 Million ≈ $1.86 Million	-13.20pp
2021-12-31	13.59%	CA$310.00K ≈ $224.25K	CA$2.28 Million ≈ $1.65 Million	-75.35pp
2008-12-31	88.94%	CA$1.58 Million ≈ $1.15 Million	CA$1.78 Million ≈ $1.29 Million	--

pp = percentage points

About Avricore Health Inc

V:AVCR Canada Diagnostics & Research

Market Cap

$5.48 Million

CA$7.58 Million CAD

Market Cap Rank

#28495 Global

#1260 in Canada

Share Price

CA$0.06

Change (1 day)

+0.00%

52-Week Range

CA$0.05 - CA$0.09

All Time High

CA$8.32